GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) » Definitions » 5-Year Yield-on-Cost %

GlaxoSmithKline Pharmaceuticals (BOM:500660) 5-Year Yield-on-Cost % : 3.14 (As of May. 05, 2024)


View and export this data going back to 1991. Start your Free Trial

What is GlaxoSmithKline Pharmaceuticals 5-Year Yield-on-Cost %?

GlaxoSmithKline Pharmaceuticals's yield on cost for the quarter that ended in Dec. 2023 was 3.14.


The historical rank and industry rank for GlaxoSmithKline Pharmaceuticals's 5-Year Yield-on-Cost % or its related term are showing as below:

BOM:500660' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.78   Med: 3.57   Max: 8.81
Current: 3.14


During the past 13 years, GlaxoSmithKline Pharmaceuticals's highest Yield on Cost was 8.81. The lowest was 1.78. And the median was 3.57.


BOM:500660's 5-Year Yield-on-Cost % is ranked better than
63.2% of 500 companies
in the Drug Manufacturers industry
Industry Median: 2.145 vs BOM:500660: 3.14

Competitive Comparison of GlaxoSmithKline Pharmaceuticals's 5-Year Yield-on-Cost %

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Pharmaceuticals's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GlaxoSmithKline Pharmaceuticals's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Pharmaceuticals's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Pharmaceuticals's 5-Year Yield-on-Cost % falls into.



GlaxoSmithKline Pharmaceuticals 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of GlaxoSmithKline Pharmaceuticals is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

GlaxoSmithKline Pharmaceuticals  (BOM:500660) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


GlaxoSmithKline Pharmaceuticals 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Pharmaceuticals's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


GlaxoSmithKline Pharmaceuticals (BOM:500660) Business Description

Traded in Other Exchanges
Address
Dr. Annie Besant Road, GSK House, Worli, Mumbai, MH, IND, 400 030
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives most of its revenue from India.

GlaxoSmithKline Pharmaceuticals (BOM:500660) Headlines

No Headlines